Search results
Results from the WOW.Com Content Network
The more general Ramanujan–Petersson conjecture for holomorphic cusp forms in the theory of elliptic modular forms for congruence subgroups has a similar formulation, with exponent (k − 1)/2 where k is the weight of the form.
In mathematics, a mock modular form is the holomorphic part of a harmonic weak Maass form, and a mock theta function is essentially a mock modular form of weight 1 / 2 . The first examples of mock theta functions were described by Srinivasa Ramanujan in his last 1920 letter to G. H. Hardy and in his lost notebook .
In mathematics, a Ramanujan–Sato series [1] [2] generalizes Ramanujan’s pi formulas such as, = = ()!! + to the form = = + by using other well-defined sequences of integers obeying a certain recurrence relation, sequences which may be expressed in terms of binomial coefficients (), and ,, employing modular forms of higher levels.
Ramanujan (1916) observed, but did not prove, the following three properties of τ(n): τ(mn) = τ(m)τ(n) if gcd(m,n) = 1 (meaning that τ(n) is a multiplicative function); τ(p r + 1) = τ(p)τ(p r) − p 11 τ(p r − 1) for p prime and r > 0.
A modular form for G of weight k is a function on H satisfying the above functional equation for all matrices in G, that is holomorphic on H and at all cusps of G. Again, modular forms that vanish at all cusps are called cusp forms for G. The C-vector spaces of modular and cusp forms of weight k are denoted M k (G) and S k (G), respectively.
Dialing Back on Sweetness. Word is getting out that high amounts of sugar isn’t so sweet for your body.The trending team at IFT confirms that 65% of U.S. consumers would prefer less sweet foods ...
In July 2003, TRG was listed on the Karachi Stock Exchange following an initial public offering at a strike price of PKR 10. [5] In November 2003, TRG acquired a 40 percent stake in Centratel LLC, a provider of call center and telephone answering services in Bend, Oregon. [6] Previously, it made an investment in Los Angeles–based Alert ...
Novo Nordisk CEO Lars Fruergaard Joergensen in December during a presentation of a new production site. The company's latest attempt at a weight loss drug, CagriSema, matched the bar set by a ...